← FDA Drug Approvals (Drugs@FDA)
NADOLOL AND BENDROFLUMETHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IMPAX LABS · Approved 2007-03-30
Drug application
- FDA Application #
ANDA077833- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NADOLOL AND BENDROFLUMETHIAZIDE
- Generic name
- Bendroflumethiazide
- Active ingredients
- BENDROFLUMETHIAZIDE; NADOLOL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- IMPAX LABS
- First approval
- 2007-03-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown